Fig. 1From: Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus Effect of i.v. administration of AZE in anesthetized and ventilated rats. The ICP (A), MAP (C) and etCO2 (E) is presented as 5 min average values normalized to the baseline (10 min average value obtained before control solution or AZE administration, 100 mg kg−1) as a function of time. The change from baseline at 2 h after the injection is shown for ICP (B, n = 5, P < 0.01, unpaired t-test) and MAP (D, n = 5, P = 0.9, unpaired t-test). Blood gas analysis was performed before (0 h) and 1 and 2 h after the injection, and results are presented for pCO2 (F, n = 5, P > 0.9 at 0 h, P < 0.001 at 1 and 2 h, 2way ANOVA with Bonferroni’s post-hoc analysis) and for blood HCO3− (G, n = 5, P < 0.001 for time variable, P < 0.05 for treatment variable, shown above bars, 2way ANOVA). Arrow indicates time of i.v. injection. ICP – intracranial pressure, MAP – mean arterial pressure, etCO2 – end tidal carbon dioxide, pCO2 – partial carbon dioxide pressure, CTRL – control, AZE – acetazolamide. Data are shown as mean ± SD. *; P < 0.05, **; P < 0.01, ***; P < 0.001, ns; not significant.Back to article page